284 related articles for article (PubMed ID: 31846834)
21. Alternative Lengthening of Telomeres in the Budding Yeast
Cohn M; Andersson AK; Mateo RQ; Möller MC
G3 (Bethesda); 2019 Oct; 9(10):3345-3358. PubMed ID: 31427453
[TBL] [Abstract][Full Text] [Related]
22. Telomere maintenance by telomerase and by recombination can coexist in human cells.
Cerone MA; Londono-Vallejo JA; Bacchetti S
Hum Mol Genet; 2001 Sep; 10(18):1945-52. PubMed ID: 11555631
[TBL] [Abstract][Full Text] [Related]
23. ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2.
Bluhm A; Viceconte N; Li F; Rane G; Ritz S; Wang S; Levin M; Shi Y; Kappei D; Butter F
Nucleic Acids Res; 2019 Feb; 47(4):1896-1907. PubMed ID: 30629181
[TBL] [Abstract][Full Text] [Related]
24. Genetic Inactivation of ATRX Leads to a Decrease in the Amount of Telomeric Cohesin and Level of Telomere Transcription in Human Glioma Cells.
Eid R; Demattei MV; Episkopou H; Augé-Gouillou C; Decottignies A; Grandin N; Charbonneau M
Mol Cell Biol; 2015 Aug; 35(16):2818-30. PubMed ID: 26055325
[TBL] [Abstract][Full Text] [Related]
25. Alternative lengthening of telomeres (ALT) cells viability is dependent on C-rich telomeric RNAs.
Rosso I; Jones-Weinert C; Rossiello F; Cabrini M; Brambillasca S; Munoz-Sagredo L; Lavagnino Z; Martini E; Tedone E; Garre' M; Aguado J; Parazzoli D; Mione M; Shay JW; Mercurio C; d'Adda di Fagagna F
Nat Commun; 2023 Nov; 14(1):7086. PubMed ID: 37925537
[TBL] [Abstract][Full Text] [Related]
26. The exoribonuclease XRN2 mediates degradation of the long non-coding telomeric RNA TERRA.
Reiss M; Keegan J; Aldrich A; Lyons SM; Flynn RL
FEBS Lett; 2023 Jul; 597(14):1818-1836. PubMed ID: 37191774
[TBL] [Abstract][Full Text] [Related]
27. The alternative lengthening of telomeres mechanism jeopardizes telomere integrity if not properly restricted.
Silva B; Arora R; Azzalin CM
Proc Natl Acad Sci U S A; 2022 Sep; 119(39):e2208669119. PubMed ID: 36122232
[TBL] [Abstract][Full Text] [Related]
28. NHP2 downregulation counteracts hTR-mediated activation of the DNA damage response at ALT telomeres.
Raghunandan M; Geelen D; Majerova E; Decottignies A
EMBO J; 2021 Mar; 40(6):e106336. PubMed ID: 33595114
[TBL] [Abstract][Full Text] [Related]
29. ZBTB40 is a telomere-associated protein and protects telomeres in human ALT cells.
Zhou M; Cui Y; Zuo S; Peng Q; Liu Y; Li X; Yang Y; He Q; Yu X; Zhou J; He Z; He Q
J Biol Chem; 2023 Sep; 299(9):105053. PubMed ID: 37454741
[TBL] [Abstract][Full Text] [Related]
30. MutSβ regulates G4-associated telomeric R-loops to maintain telomere integrity in ALT cancer cells.
Sakellariou D; Bak ST; Isik E; Barroso SI; Porro A; Aguilera A; Bartek J; Janscak P; Peña-Diaz J
Cell Rep; 2022 Apr; 39(1):110602. PubMed ID: 35385755
[TBL] [Abstract][Full Text] [Related]
31. TERRA and RAD51AP1 promote alternative lengthening of telomeres through an R- to D-loop switch.
Yadav T; Zhang JM; Ouyang J; Leung W; Simoneau A; Zou L
Mol Cell; 2022 Nov; 82(21):3985-4000.e4. PubMed ID: 36265486
[TBL] [Abstract][Full Text] [Related]
32. RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells.
Arora R; Lee Y; Wischnewski H; Brun CM; Schwarz T; Azzalin CM
Nat Commun; 2014 Oct; 5():5220. PubMed ID: 25330849
[TBL] [Abstract][Full Text] [Related]
33. Telomere elongation chooses TERRA ALTernatives.
Arora R; Azzalin CM
RNA Biol; 2015; 12(9):938-41. PubMed ID: 26158306
[TBL] [Abstract][Full Text] [Related]
34. Single-molecule analysis of subtelomeres and telomeres in Alternative Lengthening of Telomeres (ALT) cells.
Abid HZ; McCaffrey J; Raseley K; Young E; Lassahn K; Varapula D; Riethman H; Xiao M
BMC Genomics; 2020 Jul; 21(1):485. PubMed ID: 32669102
[TBL] [Abstract][Full Text] [Related]
35. Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors.
Flynn RL; Cox KE; Jeitany M; Wakimoto H; Bryll AR; Ganem NJ; Bersani F; Pineda JR; Suvà ML; Benes CH; Haber DA; Boussin FD; Zou L
Science; 2015 Jan; 347(6219):273-7. PubMed ID: 25593184
[TBL] [Abstract][Full Text] [Related]
36. A preclinical mouse model of glioma with an alternative mechanism of telomere maintenance (ALT).
Jeitany M; Pineda JR; Liu Q; Porreca RM; Hoffschir F; Desmaze C; Silvestre DC; Mailliet P; Junier MP; Londoño-Vallejo A; Ségal-Bendirdjian E; Chneiweiss H; Boussin FD
Int J Cancer; 2015 Apr; 136(7):1546-58. PubMed ID: 25175359
[TBL] [Abstract][Full Text] [Related]
37. Variant repeats are interspersed throughout the telomeres and recruit nuclear receptors in ALT cells.
Conomos D; Stutz MD; Hills M; Neumann AA; Bryan TM; Reddel RR; Pickett HA
J Cell Biol; 2012 Dec; 199(6):893-906. PubMed ID: 23229897
[TBL] [Abstract][Full Text] [Related]
38. TRF1 phosphorylation on T271 modulates telomerase-dependent telomere length maintenance as well as the formation of ALT-associated PML bodies.
Ho A; Wilson FR; Peragine SL; Jeyanthan K; Mitchell TR; Zhu XD
Sci Rep; 2016 Nov; 6():36913. PubMed ID: 27841304
[TBL] [Abstract][Full Text] [Related]
39. Alternative Lengthening of Telomeres is characterized by reduced compaction of telomeric chromatin.
Episkopou H; Draskovic I; Van Beneden A; Tilman G; Mattiussi M; Gobin M; Arnoult N; Londoño-Vallejo A; Decottignies A
Nucleic Acids Res; 2014 Apr; 42(7):4391-405. PubMed ID: 24500201
[TBL] [Abstract][Full Text] [Related]
40. FANCD2 limits BLM-dependent telomere instability in the alternative lengthening of telomeres pathway.
Root H; Larsen A; Komosa M; Al-Azri F; Li R; Bazett-Jones DP; Stephen Meyn M
Hum Mol Genet; 2016 Aug; 25(15):3255-3268. PubMed ID: 27427384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
